Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 103.30M | $ 195.80M | $ 52.20M | $ 343.80M | $ 137.10M |
Total Assets | $ 1.55B | $ 1.49B | $ 1.60B | $ 1.45B | $ 1.46B |
Total Debt | $ 272.50M | $ 197.10M | $ 240.00M | $ 206.10M | $ 160.10M |
Net Debt | $ 169.20M | $ 1.30M | $ 187.80M | $ -137.70M | $ 23.00M |
Total Liabilities | - | $ 807.90M | $ 970.10M | $ 714.50M | $ 814.30M |
Stockholders Equity | $ 585.20M | $ 678.80M | $ 628.40M | $ 731.10M | $ 649.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |